Navigation Links
CPM Helps Physicians Group Retain Patients with New Kind of House Call

Preliminary results indicate that the relationship patients have with their doctors is paramount," said John Hallick, CPM president and CEO. "The campaign aimed to get patients to see their physicians as someone to visit to maintain health instead of just for treating illness. These physicians want their patients to see them as their overall primary health experts."

The health system is c......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 02/25/03


Page: 1 2

Related biology technology :

1. TDS Helps Florida Hospitals Implement High-Speed VPN
2. OpGen Database Helps to Reduce Bioterrorist Threat
3. Schneider Logistics Helps Manufacturers Secure Competitive Advantage
4. Technology Helps Our Economy to Survive and Grow
5. WorkWise Helps Manufacturers Squeeze Bottom Line
6. Institute Helps Industries Enhance Business Strategies
7. Physicians Plus to make alternative drug info available online
8. Physicians benefit from CRM tools
9. Cardinal Health likes growth potential of Viasys NeuroCare Group
10. CIO Leadership Series: Kathi Christian, QTI Group
11. Group promoting classified research elects officers
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: CPM Helps Physicians Group Retain Patients with New Kind House Call

Breaking Biology News(10 mins):Munich lab demonstrates diesel truck engine with barely measurable emissions 2Munich lab demonstrates diesel truck engine with barely measurable emissions 3Stem cells battle for space 2FDA Warnings on Mercury Tooth Fillings Expected Today 3A New Regulation Result of Lawsuit Settled Last Year 52911 1FDA Warnings on Mercury Tooth Fillings Expected Today 3A New Regulation Result of Lawsuit Settled Last Year 52911 2FDA Warnings on Mercury Tooth Fillings Expected Today 3A New Regulation Result of Lawsuit Settled Last Year 52911 3United States FDA Clears the REGEN Trial to Test Biohearts Combination Gene and Stem Cell Therapy in Heart Failure Patients 13229 1United States FDA Clears the REGEN Trial to Test Biohearts Combination Gene and Stem Cell Therapy in Heart Failure Patients 13229 2United States FDA Clears the REGEN Trial to Test Biohearts Combination Gene and Stem Cell Therapy in Heart Failure Patients 13229 3United States FDA Clears the REGEN Trial to Test Biohearts Combination Gene and Stem Cell Therapy in Heart Failure Patients 13229 4URAC Launches New eLearning Courses for Health Care Management Accreditation 52906 1URAC Launches New eLearning Courses for Health Care Management Accreditation 52906 2URAC Launches New eLearning Courses for Health Care Management Accreditation 52906 3URAC Launches New eLearning Courses for Health Care Management Accreditation 52906 4